Cagrilintide (5mg & 10mg) Research Peptide: A Dual Amylin & Calcitonin Receptor Agonist for Metabolic Studies

If your research focuses on satiety signalling, energy balance, or the development of next‑generation anti‑obesity therapeutics, Cagrilintide (5mg & 10mg) research peptide offers a precisely defined and mechanistically distinct synthetic tool. Cagrilintide (AM833) is a long‑acting, lipidated analogue of the pancreatic hormone amylin, engineered to address a key limitation of native amylin—its short half‑life.

As a dual amylin and calcitonin receptor agonist (DACRA), it binds non‑selectively to amylin receptors (AMY1R, AMY2R, AMY3R) and the calcitonin receptor (CTR), activating Gs‑coupled signalling pathways that induce satiety and reduce food intake. This distinct mode of action—separate from GLP‑1‑based therapies—positions Cagrilintide (5mg & 10mg) research peptide as a valuable tool for laboratories investigating metabolic regulation, obesity pathophysiology, and the neural circuits that control feeding behaviour.

At Wuhan Top Miracle Peptides, we supply high‑purity Cagrilintide (5mg & 10mg) research peptide to research institutions and wholesale buyers across the United Kingdom, France, Germany, Spain, Sweden, Italy, and the USA. Every batch is lyophilised, HPLC‑verified to ≥98% purity, and accompanied by a Certificate of Analysis (COA), ensuring your investigations into metabolic regulation, satiety signalling, and obesity research begin with uncompromising quality.

What Is Cagrilintide (5mg & 10mg) and How Does It Work?

To fully appreciate the research potential of Cagrilintide (5mg & 10mg) research peptide, it is essential to understand its biochemical design and the precise mechanisms by which it exerts its effects.

The Lipidated Amylin Analogue

Cagrilintide is a 37‑amino‑acid linear synthetic peptide conjugated to a C20 fatty diacid through a hydrophilic linker at the lysine residue at position 1. This lipidated structure extends its half‑life, enabling once‑weekly administration in clinical research. The peptide includes a disulfide bridge between cysteine residues at positions 3 and 8.

Mechanism of Action: Dual Amylin & Calcitonin Receptor Agonism

The biological activity of Cagrilintide (5mg & 10mg) research peptide is mediated through its non‑selective activation of amylin and calcitonin receptors:

• Receptor Binding: Cagrilintide binds to amylin receptors (AMY1R, AMY2R, AMY3R) and the calcitonin receptor (CTR) with high affinity, exhibiting binding IC₅₀ values of 170 pM and 223 pM for hAMY3R and hCTR, respectively. Its binding mode at the receptor transmembrane bundle level is distinct from other DACRAs.

• Gs‑Protein Signalling: Receptor activation stimulates Gs‑protein signalling, increasing intracellular cAMP levels. Functional analyses reveal that cagrilintide non‑selectively activates Gs signalling pathways through both CTR and AMY1R.

• Neural Mediation of Energy Balance: Cagrilintide exerts its effects on energy balance through the dorsal vagal complex (DVC) of the brainstem. Long‑term treatment upregulates prolactin‑releasing hormone (Prlh) expression in Calcr/Prlh neurons of the nucleus of the solitary tract—a conserved mechanism across rodents, macaques, and humans.

• Distinct Conformational Dynamics: Structural studies reveal that cagrilintide has an amylin‑like binding mode but induces distinct conformational dynamics at calcitonin‑family receptors compared to other peptides, which may contribute to its clinical efficacy.

Research Note: A Non‑Incretin Pathway for Obesity Research

Unlike GLP‑1 receptor agonists such as semaglutide and tirzepatide, which target incretin pathways, cagrilintide acts through the amylin system—a pancreatic hormone that induces satiety. This distinct mode of action makes it a valuable tool for studying complementary pathways in metabolic regulation. In clinical trials, co‑administration of cagrilintide with semaglutide (CagriSema) has achieved 22.7% weight loss over 68 weeks, compared to 16.1% for semaglutide alone.

Key Research Applications for Cagrilintide (5mg & 10mg)

Cagrilintide (5mg / 10mg) research peptide is a versatile tool with applications spanning several domains of biomedical research.

1. Obesity & Metabolic Research

As a potent inducer of weight loss through satiety signalling, cagrilintide is a valuable tool for studying obesity pathophysiology. Research applications include:

• Satiety Signalling Pathways: Investigating the neural circuits and molecular mechanisms through which amylin receptor activation reduces food intake.

• Energy Balance Studies: Exploring how cagrilintide modulates energy expenditure and metabolic rate.

• Combination Therapies: Studying the synergistic effects of cagrilintide with GLP‑1 receptor agonists in preclinical models.

• Dose‑Response Studies: Characterising the dose‑dependent effects of cagrilintide on food intake and body weight.

2. Receptor Pharmacology & Signalling Research

As a non‑selective agonist of amylin and calcitonin receptors, cagrilintide serves as a molecular probe for studying receptor pharmacology:

• Receptor Binding Assays: Characterising the affinity and selectivity of cagrilintide for AMYRs and CTR.

• Signal Transduction Studies: Dissecting the Gs‑protein signalling pathways activated by dual receptor engagement.

• Structure‑Activity Relationship (SAR) Studies: Investigating how modifications to the cagrilintide sequence affect receptor binding and activity.

• Cryo‑EM Structural Studies: Using cagrilintide as a tool to elucidate receptor complex structures.

3. Neuroscience & Brain‑Gut Axis Research

Cagrilintide’s effects on the dorsal vagal complex make it a valuable tool for studying the neural control of feeding:

• Brainstem Circuitry: Investigating how cagrilintide modulates neuronal populations in the area postrema and nucleus of the solitary tract.

• Prlh Signalling: Studying the role of prolactin‑releasing hormone in mediating the effects of amylin receptor agonists.

• Cross‑Species Conservation: Exploring conserved neural mechanisms of energy balance regulation.

4. Type 2 Diabetes Research

Amylin receptor agonists have demonstrated potential in glycemic control. Research applications include:

• Prandial Glucagon Suppression: Investigating how cagrilintide suppresses glucagon release and reduces postprandial hyperglycaemia.

• Combination with GLP‑1 Agonists: Studying the effects of cagrilintide‑semaglutide combinations on glycemic control.

• Diabetes‑Associated Kidney Complications: Exploring the potential benefits of cagrilintide in diabetic kidney disease models.

5. Metabolic Disease Research

Cagrilintide is being investigated for its broader metabolic effects:

• Fatty Liver Disease: Studying the potential therapeutic benefits of long‑acting AMYR agonists in models of fatty liver disease.

• Resistant Hypertension: Investigating the effects of amylin receptor activation on blood pressure regulation.

Chemical & Physical Specifications for Cagrilintide (5mg & 10mg)

Accurate characterisation of Cagrilintide (5mg / 10mg) research peptide is essential for reproducible experimental design.

Note: The 5 mg and 10 mg masses refer to the weight of the peptide in its lyophilised form. Cagrilintide is typically supplied as an acetate salt. The peptide is for research use only. Not for human use.

Reconstitution & Handling Protocol for Cagrilintide (5mg & 10mg)

Proper reconstitution of Cagrilintide (5mg & 10mg) research peptide is critical for maintaining its structural integrity and biological activity.

Step 1 – Preparation

• Bring the sealed cagrilintide vial and your chosen diluent (sterile bacteriostatic water or sterile PBS, pH 5‑7) to room temperature. Condensation can degrade the lyophilised powder.

• Clean your work surface with 70% ethanol and lay out sterile syringes, alcohol wipes and a clean work mat.

Step 2 – Vial Sanitisation

• Wipe the rubber stopper of the cagrilintide vial with a fresh 70% ethanol wipe. Allow the alcohol to evaporate completely before piercing.

Step 3 – Reconstitution

• Draw your desired volume of diluent into a sterile syringe. A common starting concentration for research applications is 5 mg or 10 mg per 1 mL of diluent, yielding a 5‑10 mg/mL stock solution.

• Insert the needle and slowly inject the diluent against the inner glass wall. Do not spray directly onto the lyophilised powder.

• Gently swirl the vial until the solution is clear and fully dissolved. Cagrilintide is soluble in water at up to 100 mg/mL with ultrasonication. Do not shake vigorously, as shaking can cause denaturation.

Step 4 – Aliquoting & Storage

• Immediately after dissolution, aliquot the reconstituted cagrilintide into single‑use sterile vials.

• Store aliquots at –20°C for up to 1 month or at –80°C for up to 6 months.

• Avoid repeated freeze‑thaw cycles, as peptides are susceptible to degradation.

• Once thawed, store at 2‑8°C and use within a short period.

Concentration Reference Table

Adjust diluent volume based on your experimental requirements. For cell culture applications, typical working concentrations may range from 0.1‑10 µM.

Storage & Stability Guidelines for Cagrilintide (5mg & 10mg)

Why Choose Wuhan Top Miracle Peptides for Cagrilintide (5mg & 10mg)?

As an authentic licensed peptide supplier based in the United Kingdom, we supply Cagrilintide (5mg / 10mg) research peptide and a wide range of research‑grade compounds under rigorous quality assurance protocols, fully aligned with Google’s E‑E‑A‑T standards (Experience, Expertise, Authoritativeness, Trustworthiness).

• Verified Purity: Independent HPLC analysis with purity guaranteed ≥98% for every batch.

• GMP‑Compliant Manufacturing: All peptides are synthesised under strict quality control conditions.

• Full Traceability: Batch‑specific Certificates of Analysis (COA) are available for every order.

• Wholesale Supply: We serve research institutions, laboratories, and wholesale buyers across the UK, EU, and USA with flexible volume pricing and reliable logistics.

• UK‑Based Regulatory Compliance: All products are supplied strictly as research‑grade chemicals for laboratory use only (RUO).

Researchers across the United Kingdom—including those at leading institutions in London, Cambridge, Oxford, Manchester, and Edinburgh—trust us for fast domestic delivery, transparent documentation and professional technical support.

FAQ: Cagrilintide (5mg & 10mg) Research Peptide

What is Cagrilintide (5mg & 10mg) research peptide?
Cagrilintide (AM833) is a long‑acting, lipidated analogue of the pancreatic hormone amylin. It is a dual agonist of amylin receptors (AMY1R, AMY2R, AMY3R) and the calcitonin receptor (CTR), functioning as a DACRA (dual amylin and calcitonin receptor agonist). It is used in research to study satiety, energy balance, and obesity.

What is the sequence and molecular weight of Cagrilintide?
Cagrilintide is a 37‑amino‑acid linear synthetic peptide with a disulfide bridge between Cys3 and Cys8. Its molecular formula is C₁₉₄H₃₁₂N₅₄O₅₉S₂, and its molecular weight is approximately 4409.01 Da.

What are the primary research applications for Cagrilintide?
Cagrilintide is used in obesity and metabolic research (satiety signalling, energy balance), receptor pharmacology and signalling studies (receptor binding, signal transduction), neuroscience and brain‑gut axis research (brainstem circuitry, Prlh signalling), type 2 diabetes research, and metabolic disease research (fatty liver disease, resistant hypertension).

What is the mechanism of action of Cagrilintide?
Cagrilintide binds non‑selectively to amylin receptors (AMY1R, AMY2R, AMY3R) and the calcitonin receptor (CTR) with high affinity (IC₅₀ of 170 pM and 223 pM respectively). It activates Gs‑protein signalling, increasing intracellular cAMP, and modulates energy balance through neural pathways in the dorsal vagal complex.

What purity does your Cagrilintide (5mg & 10mg) meet?
Our Cagrilintide is tested to ≥98% purity by HPLC. A Certificate of Analysis (COA) is supplied with every order.

How should I reconstitute Cagrilintide (5mg / 10mg)?
Reconstitute with sterile bacteriostatic water or sterile PBS (pH 5‑7). Allow the vial to reach room temperature, then slowly inject the diluent against the inner glass wall and swirl gently. Do not shake. Cagrilintide is soluble in water at up to 100 mg/mL with ultrasonication.

How should I store reconstituted Cagrilintide?
Reconstituted Cagrilintide can be stored at –20°C for up to 1 month or at –80°C for up to 6 months, sealed and protected from moisture. Avoid repeated freeze‑thaw cycles.

Is Cagrilintide research peptide legal to purchase in the UK?
Yes. Cagrilintide is a laboratory reagent sold for research use only (RUO). It is fully legal to purchase, possess, and use in the United Kingdom for legitimate in‑vitro or in‑vivo scientific research, provided it is not marketed with therapeutic claims. Note: Cagrilintide is not currently FDA‑approved as a standalone treatment. A New Drug Application for CagriSema (cagrilintide + semaglutide) was submitted to the FDA in December 2025.

Does Wuhan Top Miracle Peptides ship internationally?
Yes. We ship across the EU (France, Germany, Spain, Sweden, Italy) and to the USA from our UK warehouse. Wholesale pricing is available for bulk orders.

Wholesale Cagrilintide (5mg & 10mg) Supply Across the UK and Europe

Wuhan Top Miracle Peptides supports wholesale peptide buyers in the United Kingdom and international markets.

We Support Enquiries From:

• United Kingdom
• France
• Germany
• Spain
• Sweden
• Italy
• USA
• Wider Europe

For larger Cagrilintide (5mg & 10mg) enquiries, contact our team before ordering. This helps confirm stock, documentation, shipping options, product identity, vial strength, and buyer verification requirements.

Where to Source Cagrilintide (5mg & 10mg) in the UK

If you are searching for where to source Cagrilintide (5mg & 10mg) in the UK, Wuhan Top Miracle Peptides provides a simple professional enquiry process.

Professional Enquiry Process

1. Review the Cagrilintide (5mg & 10mg) product details.
2. Check the current label and batch information.
3. Confirm whether the batch is listed as Cagrilintide (5mg & 10mg) or another verified identity.
4. Confirm whether you need the 5mg or 10mg vial option.
5. Ask about COA and purity-related documentation.
6. Confirm the sequence and salt form where required.
7. Confirm storage information and shipping country.
8. Discuss wholesale quantity requirements.
9. Complete buyer verification where required.
10. Place a professional enquiry with support from our team.

Cagrilintide (5mg & 10mg)

Bulk Peptides Page
Shipping & Returns Page
Contact Us Page
Shop Page
Quality / Compliance Page
Retatrutide Product Page
Semaglutide Product Page
Scientific or compound reference source
GOV.UK / MHRA
Google Search Central
ASA / CAP Code Section 12

Cagrilintide (5mg & 10mg)

From its design as a lipidated, long‑acting amylin analogue to its well‑characterised role as a dual agonist of amylin and calcitonin receptors, Cagrilintide (5mg & 10mg) research peptide provides a precisely defined and mechanistically distinct platform for advanced metabolic research. Its ability to activate Gs‑signalling pathways, modulate energy balance through the dorsal vagal complex, and induce significant weight loss through satiety signalling—supported by peer‑reviewed research published in Nature Communications, Nature Metabolism, and other authoritative journals—makes it a valuable addition to any laboratory investigating obesity pathophysiology, satiety signalling, or the neural circuits that control feeding behaviour.

By choosing high‑purity, lab‑verified Cagrilintide (5mg / 10mg) research peptide from Wuhan Top Miracle Peptides, you ensure that your research is built on a foundation of quality, reproducibility, and scientific integrity.

Ready to advance your research with Cagrilintide (5mg & 10mg)? Browse our product catalogue, request a wholesale quote, or contact our support team today to discuss your laboratory’s specific needs. Place your order now and receive GMP‑grade Cagrilintide delivered directly to your facility in the UK, EU, or USA.